Clinical Trials in Canada / NCT06338787
Active, not recruiting
Not applicable
A Novel Iron-Based Supplement for Athletes Aged 14-17
NCT06338787 · tracked via the Priya Life Science Canada tracker
Condition(s) studied
Iron Deficiencies
Investigational drug(s) / intervention(s)
FeSC
FeSC: Iron/yeast complex
Study summary
Female endurance athletes are susceptible to iron deficiency and this can impact their exercise performance. This study aims to assess the efficacy of a novel iron supplement in improving iron status, gut microbiome, and exercise performance in endurance-trained females.
Eligibility
Inclusion Criteria:
* cis-gendered female 14-18 years old
* sub-optimal iron status (ferritin ≤45mcg/ L)
* At least 1 year past the age of menarche
* Engage in moderate to vigorous endurance activity for at least 3 hours a week
Exclusion Criteria:
* Supplemented with iron iron (\>5mg/day), prebiotics, or probiotics in last 3 months
* antibiotic use in last 3 months
* \- Energy availability \>30 kcal/kg lean body mass
Primary outcome measure(s)
- Iron Status — Baseline, 4 weeks, 8 weeks
Ferritin - Hemoglobin — Baseline, 4 weeks, 8 weeks
Hemoglobin concentration - Lower Gut microbiome — Baseline, 4 weeks, 8 weeks
Fecal sample
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Calgary | Calgary | Alberta |
More University of Calgary trials in Canada
EVS With Exercise for Balance With Older Adults
Starting soon
NC Testing in LC & POTS
Recruiting
Cardiovascular Imaging Registry of Canada
Recruiting
Other trials for the same condition
A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06338787 on ClinicalTrials.gov ↗ ← All trials in Canada